An overview of metformin in the treatment of type 2 diabetes mellitus.
about
Shizukaol D isolated from Chloranthus japonicas inhibits AMPK-dependent lipid content in hepatic cells by inducing mitochondrial dysfunctionOral hypoglycaemic drugs and gastrointestinal symptoms in diabetes mellitus.Metformin-associated lactic acidosis: a rare or very rare clinical entity?Blood glycemia-modulating effects of melanian snail protein hydrolysates in mice with type II diabetes.New directions in type 2 diabetes mellitus: an update of current oral antidiabetic therapy.Influence of oral antidiabetic drugs on hyperglycemic response to foods in persons with type 2 diabetes mellitus as assessed by continuous glucose monitoring system: a pilot study.Effect of centchroman coadministration on the pharmacokinetics of metformin in rats.Role of the kidney in normal glucose homeostasis and in the hyperglycaemia of diabetes mellitus: therapeutic implications.Using dose-response characteristics of therapeutics agents for treatment decisions in type 2 diabetes.Physiology of glucose homeostasis.Glargine safety, diabetes and cancer.Determinants of glycaemic control in a practice setting: the role of weight loss and treatment adherence (The DELTA Study).Buformin exhibits anti-proliferative and anti-invasive effects in endometrial cancer cells"Low dose" metformin improves hyperglycemia better than acarbose in type 2 diabetics.Therapeutic Concentrations of Metformin: A Systematic Review.Metformin does not enhance ovulation induction in clomiphene resistant polycystic ovary syndrome in clinical practice.Statin use as a moderator of metformin effect on risk for prostate cancer among type 2 diabetic patientsPharmacologic treatment of type 2 diabetic dyslipidemia.Insulin Therapy of Nondiabetic Septic Patients Is Predicted by para-Tyrosine/Phenylalanine Ratio and by Hydroxyl Radical-Derived Products of PhenylalanineMetformin-induced lactic acidosis: a case seriesFermentation of Green Tea with 2% Aquilariae lignum Increases the Anti-Diabetic Activity of Green Tea Aqueous Extracts in the High Fat-Fed Mouse.Antidiabetic Effects of Add-On Gynostemma pentaphyllum Extract Therapy with Sulfonylureas in Type 2 Diabetic Patients.Metformin.Management of diabetes in patients with chronic kidney disease.Metformin: clinical use in type 2 diabetes.Novel Therapeutics for Diabetes: Uptake, Usage Trends, and Comparative Effectiveness.Metformin Use Is Associated with Improved Survival in Patients Undergoing Resection for Pancreatic Cancer.NYGGF4 (PID1) effects on insulin resistance are reversed by metformin in 3T3-L1 adipocytes.Chronic insulin effects on insulin signalling and GLUT4 endocytosis are reversed by metformin.Improved glycaemic control by addition of glimepiride to metformin monotherapy in type 2 diabetic patients.Evaluation of the safety and efficacy of sibutramine, orlistat and metformin in the treatment of obesity.Predictors of insulin sensitivity in Type 2 diabetes mellitus.Effects of short-term metformin treatment on insulin sensitivity of blood glucose and free fatty acids.Gender-dependent attenuation of cardiac potassium currents in type 2 diabetic db/db mice.Formulation, physicochemical characterization and in-vivo evaluation of ion-sensitive metformin loaded-biopolymeric beads.Investigation of the Role of a Supplementation with Taurine on the Effects of Hypoglycemic-Hypotensive Therapy Against Diabetes-Induced Nephrotoxicity in Rats.Safety and efficacy of metformin up-titration in Japanese patients with type 2 diabetes mellitus treated with vildagliptin and low-dose metformin.A comparative study on effect of metformin and metformin-conjugated nanotubes on blood glucose homeostasis in diabetic rats.Effect of metformin plus roziglitazone compared with metformin alone on glycaemic control in well-controlled Type 2 diabetes.The protective potential of metformin against acetaminophen-induced hepatotoxicity in BALB/C mice.
P2860
Q28535328-87E5ED09-5688-4554-A405-4CF1590F5B7AQ31795272-EB01CB09-443A-4491-8139-A216E4D1CCF0Q33603791-C0FD036F-6EF3-435D-A90A-97C5C45B1004Q33675056-A987CDC4-F445-4430-9D4B-93D6B2B72A96Q33821892-4C1A28FD-1F06-42CF-A6B1-8FC47AE346BDQ34018170-A9E0E791-DC46-4006-8F64-C09FA266A5CEQ34118868-B11C4772-FA23-41B4-8032-5672274A7464Q34120717-C77CFC35-46D2-4C8C-A1E4-0C5D5A923F78Q34163377-06A17CC4-838E-43E9-B3FF-F2F0B0781F12Q34166745-6B99731A-2EF3-41D7-A822-4FC7F018ADA8Q34326924-78B8924C-DA04-4E69-9BB5-940E24F99C08Q34516192-9F0CF080-3874-4466-827F-0D34F5531E7BQ34533709-DF62607A-B7F5-4A15-A5F1-279C7FBE2D08Q35612646-98D2AFD0-CCCD-4FB8-AC41-C07EE468C99AQ35761723-D5D8A254-F436-4871-82B3-7CF12DF4D2FEQ35803853-2E482EB8-5EB0-4C1C-A517-C7EED6B2A498Q35898302-19C5511D-55C1-4463-8E1D-B62712823F54Q35976827-37134C16-E0D4-4AAA-B6E8-52330C841665Q36242250-D09375F9-C692-4CD9-A2DC-7B4BBC8DF539Q36316126-C761ED6E-5416-4E3D-AC83-88BA03A3E597Q36329786-18A23A19-7CD0-4179-BC14-157382C274BEQ36357709-4D12CCC5-8C2C-4FE3-ABE4-078B27589DF2Q37083602-5956D5FC-CC02-4A29-9479-81269C3A5CD9Q37505862-30F85D69-EB73-46E5-9C14-57FBBF0B3C0FQ38645273-03ACF1FA-435C-46C9-9788-B1553C602E63Q38807857-207D0292-CA4A-4D25-A9FB-DD6340979131Q39714372-5C954174-06CD-42DE-830E-A29B02AD5A76Q42830825-EAA36826-ED5D-4CDD-980F-5E503261F15CQ42996602-9C428B39-B241-4F2D-84AF-12745B6B991BQ43778450-E002AA28-676C-4F68-8D33-342715737969Q43902800-07CB5171-5FC9-4E7C-9A76-87FDD38D9A65Q44051661-899B1821-4E7F-4731-BC77-651CBB2E4BF0Q44700351-CCE2E314-E8A3-49C8-8B89-A13A270C6076Q44705248-BC8A7B8C-4175-41BC-847A-7BEB11692C4AQ46425986-56D8C1DB-603C-49F7-9E49-6102D5BD859FQ47890276-D5827570-AF3F-42F4-A2CF-A008F8DC8AA4Q49991307-DD16F8D6-1997-4227-9610-CC95027E4C3DQ51320046-52E7ADA8-90DD-4367-BC26-36A56BB16854Q51489759-CB0FE08B-4A50-4652-A547-66FCC70A8FA8Q51725045-3616B38C-CFEA-4492-83BD-457A12919BF9
P2860
An overview of metformin in the treatment of type 2 diabetes mellitus.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
An overview of metformin in the treatment of type 2 diabetes mellitus.
@en
type
label
An overview of metformin in the treatment of type 2 diabetes mellitus.
@en
prefLabel
An overview of metformin in the treatment of type 2 diabetes mellitus.
@en
P1476
An overview of metformin in the treatment of type 2 diabetes mellitus.
@en
P2093
Davidson MB
P304
P356
10.1016/S0002-9343(96)00353-1
P407
P577
1997-01-01T00:00:00Z